Why Is Amgen Rising And Regeneron Falling?
June 11, 2015 at 15:42 PM EDT
An FDA advisory panel voted 11-4 Thursday to recommend a new type of cholesterol-lowering drug from Amgen (AMGN), but suggested limiting use to patients with a high risk of cardiovascular disease. Sound familiar? Regeneron (REGN) got similar treatment from the same panel yesterday, with advisers voting 13 to 3 to recommend approval of the experimental [...]
